Anti-Infective Agents Market By Drug Class (Antibiotics, Antivirals, Antifungals, Antiprotozoals, Anthelmintics, Others), By Application (Skin Infections, Respiratory Tract Infections, Gastrointestinal Infections, Central Nervous System Infections, Others), By Route of Administration (Oral, Topical, Injectable, Inhalation), By End-User (Hospitals and Clinics, Homecare Settings, Ambulatory Surgical Centers (ASCs),Research and Diagnostic Laboratories), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Drug Type

• Antibiotics
• Antivirals
• Antifungals
• Antiprotozoals
• Anthelmintics
• Others

By Application

• Skin Infections
• Respiratory Tract Infections
• Gastrointestinal Infections
• Central Nervous System Infections
• Others

By Route of Administration

• Oral
• Topical
• Injectable
• Inhalation

By End-User

• Hospitals and Clinics
• Homecare Settings
• Ambulatory Surgical Centers (ASCs)
• Research and Diagnostic Laboratories

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Pfizer Inc.
• Merck & Co., Inc.
• GlaxoSmithKline (GSK)
• Johnson & Johnson
• Novartis AG
• Sanofi S.A.
• Spexis AG
• AstraZeneca PLC
• Eli Lilly and Company
• Bristol-Myers Squibb
• Teva Pharmaceutical Industries Ltd.
• F. Hoffmann-La Roche Ltd.
• Mylan N.V.
• Allergan
• Basilea Pharmaceutical
• Globe Biotech Ltd.
• Cubist Pharmaceuticals